Reviews in Endocrine & Metabolic Disorders

Papers
(The H4-Index of Reviews in Endocrine & Metabolic Disorders is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Application of radiomics and machine learning to thyroid diseases in nuclear medicine: a systematic review135
Looking beyond fat in obesity: the frequently overlooked importance of muscle mass124
Patient and health care provider knowledge of diabetes and diabetic microvascular complications: a comprehensive literature review114
Pegvisomant in managing comorbidities of acromegaly: a review111
Traumatic brain injury and prolactin100
Effectiveness and safety of continuous subcutaneous hydrocortisone infusion in managing adrenocortical insufficiency in adult patients: a systematic review93
Insulin icodec: A novel once-weekly formulation for the treatment of type 1 and type 2 diabetes mellitus88
Association between continuous glucose monitoring metrics and cardiovascular autonomic neuropathy in diabetic patients: a systematic review74
The genetics of Graves’ disease69
Pathophysiological insights into asprosin: an emerging adipokine in reproductive health62
Predictors of incident diabetic peripheral neuropathy: a systematic review of longitudinal studies in patients with diabetes mellitus61
Epigenetic programming for obesity and noncommunicable disease: From womb to tomb60
Diagnostic and prognostic utility of phase angle in patients with cancer58
Replacement with sex steroids in hypopituitary men and women: implications for gender differences in morbidities and mortality56
New drugs for the treatment of obesity: do we need approaches to preserve muscle mass?55
Endocrine responses of the stress system to different types of exercise54
Prolactin deficiency in the context of other pituitary hormone abnormalities52
Preface48
Revisiting the endocrine and metabolic manifestations of COVID-19 two years into the pandemic48
Central and peripheral regulation of the GH/IGF-1 axis: GHRH and beyond47
A narrative review: CXC chemokines influence immune surveillance in obesity and obesity-related diseases: Type 2 diabetes and nonalcoholic fatty liver disease46
Androgens, aging, and prostate health45
Advances in the management of anaplastic thyroid carcinoma: transforming a life-threatening condition into a potentially treatable disease45
Use of thermal imaging in the detection of the diabetic foot- review44
Posttranslational modifications in diabetes: Mechanisms and functions43
Emerging role of AgRP neurons as integrators of metabolic, sensory and environmental cues in the control of energy homeostasis42
Mention to Prof. Andrew V. Schally40
Polycystic ovary syndrome and risks for COVID-19 infection: A comprehensive review39
A multifaceted and inclusive methodology for the detection of sarcopenia in patients undergoing bariatric surgery: an in-depth analysis of current evidence39
No longer to be ignored: Hypophosphatemia following intravenous iron administration39
Deep neural network for food image classification and nutrient identification: A systematic review38
Cancer screening in patients with acromegaly: a plea for a personalized approach and international registries38
Neurovascular plasticity as a modulator of hypothalamic function38
Preoperative systemic inflammatory markers as prognostic factors in differentiated thyroid cancer: a systematic review and meta-analysis37
Appetitive interoception, the hippocampus and western-style diet36
Hypothalamic GHRH36
The diagnosis and management of pheochromocytoma and paraganglioma during pregnancy36
0.036439895629883